Volume 9, Issue 1 (7-2011)                   IJRM 2011, 9(1): 0-0 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Amooee S, Samsami A, Jahanbakhsh J, Karimi M. The pregnancy outcome in patients with minor β-thalassemia. IJRM. 2011; 9 (1)
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-204-en.html
1- Department of Obstetrics and Gynecology, Shiraz University of Medical Sciences, Shiraz, Iran
2- Hematology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran , karimim@sums.ac.ir
Abstract:   (1445 Views)
Background: β-thalassemia is the most common hereditary disease in Iran and more than 2 million carriers of the β-thalassemia mutant gene are living in this country.
Objective: To determine pregnancy outcome of women with β-thalassemia minor.
Materials and Methods: In this retrospective, case-control study in two universities affiliated hospitals in Shiraz, all pregnancies occurred between 2006 and 2008 were included. Patients were divided in two groups regarding the presence of β-thalassemia minor. Patients in case and control groups were matched according to maternal age, gestational age and number of previous pregnancies. Cesarean delivery, hypertensive disorders, gestational diabetes mellitus, premature rupture of membranes and preterm labor were recorded in each group and were compared using the χ2 or Fisher exact tests. 
Results: Overall 510 β-thalassemia minor subjects and 512 healthy controls were studied. Cases with β-thalassemia minor had significantly higher prevalence of oligohydramnios (p<0.001) and cesarean section delivery (p=0.001). There was no significant difference regarding Apgar score in 1st (p=0.65) and 5th minute (p=0.25), IUGR (p=0.073), gestational diabetes mellitus (DM) (p=0.443) and preeclampsia (p=0.116) between two study groups.    
Conclusion: β-thalassemia minor does not significantly influence the pregnancy outcome in the negative way.
Full-Text [PDF 301 kb]   (177 Downloads) |   |   Full-Text (HTML)  (84 Views)  
Type of Study: Original Article |

1. Weatherall D, Letsky B. Genetic haematolgical disorders. In: Wald N, ed. Antenatal and Neonatal Screening. 2nd ed. Oxford: Oxford University Press; 1999.
2. Thein SL. Beta-thalassaemia. Baillieres Clin Haematol 1993; 6: 151–175. [DOI:10.1016/S0950-3536(05)80069-1]
3. karimi M, Yavarian M, Afrasiabi A, Dehbozorgian J, Rachmilewitz E. Archive Medical Research 2008; 39: 212-214.
4. Hillman R, Ault K. Hematology in Clinical Practice. 3rd ed. New York: McGraw-Hill; 2002.
5. Savona-Ventura C, Bonello F. Beta-thalassemia syndromes and pregnancy. Gynecol Surv 1994; 49: 129-137. [DOI:10.1097/00006254-199402000-00025]
6. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: Epidemiology, Prevention, and Management. J Ped Hematol Oncol 2007; 29: 333-338. [DOI:10.1097/MPH.0b013e3180437e02]
7. Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F. The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001; 25: 285–296. [DOI:10.1081/HEM-100105221]
8. Letsky E. Anemia. In: James D, Steer P, Weiner D, Gonik B, eds. High Risk Pregnancy: Management Options. 2nd ed. London: WB Saunders; 1999: 729-747.
9. Balgir RS. Infant mortality and reproductive wastage associated with different genotypes of haemoglobinopathies in Orissa, India. Annals of Human Biology 2007; 34: 16-25. [DOI:10.1080/03014460601054673]
10. ACOG practice bulletin. Clinical management guidelines for obstetricians-gynecologist. Number 64, July 2005.
11. Jensen CE, Tuck SM, Wonke B. Fertility in beta thalassaemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature. Br J Obstet Gynaecol 1995; 102: 625–629. [DOI:10.1111/j.1471-0528.1995.tb11400.x]
12. Alger LS, Golbus MS, Laros RK Jr. Thalassemia and pregnancy: results of an antenatal screening program. Am J Obstet Gynecol 1979; 134: 662–673. [DOI:10.1016/0002-9378(79)90648-3]
13. Skordis N, Christou S, Koliou M, Pavlides N, Angastiniotis M. Fertility in female patients with thalassemia. J Pediatr Endocrinol Metab 1998; 11 (Suppl): 935–943.
14. Nassar AH, Usta IM, Rechdan JB, Koussa S, Inati A, Taher A. Pregnancy in patients with beta-thalassemia intermedia: outcome of mothers and newborns. Am J Hematol 2006; 81: 499-502. [DOI:10.1002/ajh.20654]
15. Savona-Ventura C, Bonello F. Beta-thalassemia syndromes and pregnancy. Obstet Gynecol Surv 1994; 49: 129–137. [DOI:10.1097/00006254-199402000-00025]
16. Sheiner E, Levy A, Yerushalmi R, Katz M. Beta-Thalassemia Minor During Pregnancy. Obstet Gynecol 2004; 103:1273-1277. [DOI:10.1097/01.AOG.0000126575.34482.fb]
17. Liaw DC, Kotkiewicz A, Kenker MA. Acute splenic infarct in b thalassemia minor. Hemoglobin 2009; 33: 262-268. [DOI:10.1080/03630260903058651]
18. Kanavaki I, Makrythanasis P, Lazaropoulou C, Tsironi M, Kattamis A, Rombos I. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia. Blood cells Mol Dis 2009; 43: 230-234. [DOI:10.1016/j.bcmd.2009.06.002]
19. Vaeusorn O, Fucharoen S, Wasi P. A study of thalassemia associated with pregnancy. Birth Defects Orig Artic Ser 1988; 23: 295–299.

Send email to the article author

© 2021 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb